These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 34216021)
1. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine. Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021 [TBL] [Abstract][Full Text] [Related]
2. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge. Gong L; Whirl-Carrillo M; Klein TE Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics knowledge for personalized medicine. Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668 [TBL] [Abstract][Full Text] [Related]
4. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19. Huddart R; Whirl-Carrillo M; Altman RB; Klein TE Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778 [TBL] [Abstract][Full Text] [Related]
5. PharmGKB: A worldwide resource for pharmacogenomic information. Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005 [TBL] [Abstract][Full Text] [Related]
6. PGxMine: Text mining for curation of PharmGKB. Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632 [TBL] [Abstract][Full Text] [Related]
8. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Owen RP; Altman RB; Klein TE Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919 [TBL] [Abstract][Full Text] [Related]
9. Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine. Mehta D; Uber R; Ingle T; Li C; Liu Z; Thakkar S; Ning B; Wu L; Yang J; Harris S; Zhou G; Xu J; Tong W; Lesko L; Fang H Drug Discov Today; 2020 May; 25(5):813-820. PubMed ID: 32032705 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling. Schuck RN; Grillo JA AAPS J; 2016 May; 18(3):573-7. PubMed ID: 26912182 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics Clinical Annotation Tool (PharmCAT). Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493 [TBL] [Abstract][Full Text] [Related]
12. Variability of Pharmacogenomics Information in Drug Labels Approved by Different Agencies and its Ethical Implications. Güner MD; Ekmekci PE; Kurtoglu B Curr Drug Saf; 2022; 17(1):47-53. PubMed ID: 34315387 [TBL] [Abstract][Full Text] [Related]
13. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines]. Hafner S; Haubensak S; Paul T; Zolk O Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332 [No Abstract] [Full Text] [Related]
14. Enabling the curation of your pharmacogenetic study. McDonagh Em; Whirl-Carrillo M; Altman RB; Klein TE Clin Pharmacol Ther; 2015 Feb; 97(2):116-9. PubMed ID: 25670512 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view. Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752 [TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of a pharmacogenomics information resource for pharmacists. Romagnoli KM; Boyce RD; Empey PE; Ning Y; Adams S; Hochheiser H J Am Med Inform Assoc; 2017 Jul; 24(4):822-831. PubMed ID: 28339805 [TBL] [Abstract][Full Text] [Related]
17. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients. Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514 [No Abstract] [Full Text] [Related]
19. A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy. Lewandrowski KU; Sharafshah A; Elfar J; Schmidt SL; Blum K; Wetzel FT Cell Mol Neurobiol; 2024 May; 44(1):47. PubMed ID: 38801645 [TBL] [Abstract][Full Text] [Related]